PT814782E - Composicao farmaceutica estabilizada com um agente basico - Google Patents

Composicao farmaceutica estabilizada com um agente basico

Info

Publication number: PT814782E
Authority: PT; Portugal
Prior art keywords: pharmaceutical composition; basic agent; composition stabilized; composition; stabilized
Prior art date: 1995-12-22

Application number

PT96942588T

Other languages

English (en)

Inventor

Toyojiro Muramatsu

Katsumi Mashita

Yasuo Shinoda

Hironori Sassa

Hiroyuki Kawashima

Yoshio Tanizawa

Hideatsu Takeuchi Takeuchi

Original Assignee

Nissan Chemical Ind Ltd

Kowa Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-22

Filing date

1996-12-20

Publication date

2003-04-30

1996-12-20 Application filed by Nissan Chemical Ind Ltd, Kowa Co filed Critical Nissan Chemical Ind Ltd

2003-04-30 Publication of PT814782E publication Critical patent/PT814782E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Hematology (AREA)
Inorganic Chemistry (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Enzymes And Modification Thereof (AREA)
Plural Heterocyclic Compounds (AREA)

PT96942588T 1995-12-22 1996-12-20 Composicao farmaceutica estabilizada com um agente basico PT814782E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP35465495		1995-12-22

Publications (1)

Publication Number	Publication Date
PT814782E true PT814782E (pt)	2003-04-30

Family

ID=18439011

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT96942588T PT814782E (pt)	1995-12-22	1996-12-20	Composicao farmaceutica estabilizada com um agente basico

Country Status (26)

Country	Link
EP (1)	EP0814782B1 (pt)
JP (1)	JP3276962B2 (pt)
KR (1)	KR100348842B1 (pt)
CN (1)	CN1137684C (pt)
AT (1)	ATE228354T1 (pt)
AU (1)	AU725622B2 (pt)
CA (1)	CA2213608C (pt)
CZ (1)	CZ288545B6 (pt)
DE (2)	DE122011000014I1 (pt)
DK (1)	DK0814782T3 (pt)
ES (1)	ES2183023T3 (pt)
FR (1)	FR11C0007I2 (pt)
HU (1)	HU227798B1 (pt)
IL (1)	IL121565A (pt)
MX (1)	MX9706389A (pt)
NO (2)	NO316724B1 (pt)
NZ (1)	NZ324446A (pt)
PL (1)	PL186907B1 (pt)
PT (1)	PT814782E (pt)
RU (1)	RU2142790C1 (pt)
SI (1)	SI0814782T1 (pt)
SK (1)	SK282991B6 (pt)
TW (1)	TW436294B (pt)
UA (1)	UA29513C2 (pt)
WO (1)	WO1997023200A1 (pt)
ZA (1)	ZA9610792B (pt)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CO5140079A1 (es) *	1998-10-14	2002-03-22	Novartis Ag	Composicion farmaceutica de liberacion sostenida y metodo para liberar un agente farmaceuticamente activo de liberacion sostenida y metodo para liberar un agente far- maceuticamente activo
SI20109A (sl) *	1998-12-16	2000-06-30	LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.	Stabilna farmacevtska formulacija
EP1036563A1 (en) *	1999-03-08	2000-09-20	MERCK & CO. INC.	Delayed-release oral formulation of dihydroxy open acid simvastatin and salts and esters thereof
JP2002538202A (ja) *	1999-03-08	2002-11-12	メルクエンドカムパニーインコーポレーテッド	ＨＭＧ−ＣｏＡレダクターゼ阻害剤のジヒドロキシオープンアシッド及びその塩
US6569461B1 (en)	1999-03-08	2003-05-27	Merck & Co., Inc.	Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors
JP4048780B2 (ja)	1999-12-13	2008-02-20	株式会社豊田中央研究所	キノリン誘導体化合物及び有機電界発光素子
GB0001621D0 (en) *	2000-01-26	2000-03-15	Astrazeneca Ab	Pharmaceutical compositions
USRE44578E1 (en)	2000-04-10	2013-11-05	Teva Pharmaceutical Industries, Ltd.	Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids
US6242003B1 (en)	2000-04-13	2001-06-05	Novartis Ag	Organic compounds
US6806290B2 (en)	2000-06-09	2004-10-19	Lek Pharmaceuticals D.D.	Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
US6531507B1 (en)	2000-06-09	2003-03-11	Lek Pharmaceuticals D.D.	Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
US20060127474A1 (en)	2001-04-11	2006-06-15	Oskar Kalb	Pharmaceutical compositions comprising fluvastatin
TW200404544A (en) *	2002-06-17	2004-04-01	Kowa Co	Controlled release pharmaceutical composition
JP4630065B2 (ja) *	2002-09-20	2011-02-09	興和株式会社	外用剤
AR041089A1 (es)	2003-05-15	2005-05-04	Merck & Co Inc	Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas
JP2007516287A (ja)	2003-12-23	2007-06-21	メルク　エンド　カムパニー　インコーポレーテッド	抗高コレステロール血症化合物
EP1702626B1 (en)	2003-12-30	2011-11-30	Kowa Company, Ltd.	Screening method for gamma-secretase inhibitors
US8314124B2 (en)	2004-02-06	2012-11-20	Active Biotech Ab	Crystalline salts of quinoline compounds and methods for preparing them
SE0400235D0 (sv)	2004-02-06	2004-02-06	Active Biotech Ab	New composition containing quinoline compounds
WO2005079847A1 (ja)	2004-02-25	2005-09-01	Kowa Company, Ltd.	Cdc42タンパク質の核内移行促進剤及びそのスクリーニング方法
WO2005079846A1 (ja)	2004-02-25	2005-09-01	Kowa Company, Ltd.	Racタンパク質の核内移行促進剤及びそのスクリーニング方法
US20060211752A1 (en)	2004-03-16	2006-09-21	Kohn Leonard D	Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
UA87854C2 (en)	2004-06-07	2009-08-25	Мерк Энд Ко., Инк.	N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
CA2593545A1 (en)	2005-01-06	2006-07-13	Merck & Co., Inc.	Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders
EP1726962A1 (en) *	2005-05-24	2006-11-29	Leiden University Medical Center	Apolipoprotein E plasma levels for monitoring and reducing the risk of cardiovascular disease
CN101103983B (zh) *	2006-07-14	2012-09-26	海南盛科生命科学研究院	一种用碱试剂稳定的含匹伐他汀钙的药用组合物及制备工艺
JP2010530419A (ja)	2007-06-20	2010-09-09	メルク・シャープ・エンド・ドーム・コーポレイション	ジフェニル置換アルカン
US8372877B2 (en)	2010-04-16	2013-02-12	Cumberland Pharmaceuticals	Stabilized statin formulations
JPWO2012046772A1 (ja)	2010-10-06	2014-02-24	国立大学法人東京大学	リンパ浮腫予防治療剤
MX351305B (es)	2011-01-20	2017-10-09	Merck Sharp & Dohme	Antagonistas del receptor de mineralocorticoides.
EP2698159A4 (en)	2011-04-12	2014-11-05	Sawai Seiyaku Kk	PITAVASTATE-CONTAINING PREPARATION AND METHOD OF MANUFACTURING THEREOF
EP2697203B1 (en)	2011-04-13	2017-05-24	Merck Sharp & Dohme Corporation	Mineralocorticoid receptor antagonists
WO2012153181A1 (en)	2011-05-11	2012-11-15	Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi	Pharmaceutical composition comprising pitavastatin or its pharmaceutically acceptable salts
CN102861018A (zh) *	2011-07-05	2013-01-09	南京长澳医药科技有限公司	一种匹伐他汀钙制剂及其制备工艺
JP5809467B2 (ja) *	2011-07-12	2015-11-11	エルメッドエーザイ株式会社	ピタバスタチン含有組成物及びその製造方法
JP5844574B2 (ja) *	2011-08-10	2016-01-20	共和薬品工業株式会社	ピタバスタチンを含有する安定化された薬物組成物
US9505730B2 (en)	2011-10-13	2016-11-29	Merck Sharp & Dohme Corp.	Mineralocorticoid receptor antagonists
WO2014024268A1 (ja)	2012-08-08	2014-02-13	興和株式会社	医薬
CN102885797A (zh) *	2012-10-29	2013-01-23	福州海王福药制药有限公司	一种含匹伐他汀钙的组合物及其制备方法和应用
US9750723B2 (en)	2013-10-31	2017-09-05	Ohio University	Prevention and treatment of non-alcoholic fatty liver disease
KR20160147007A (ko)	2014-05-30	2016-12-21	화이자 인코포레이티드	선택적인 안드로겐 수용체 조절제로서의 카보니트릴 유도체
WO2016010609A1 (en)	2014-07-18	2016-01-21	Ohio University	Prevention and treatment of non-alcoholic fatty liver disease
CN105343008A (zh) *	2015-12-15	2016-02-24	青岛华之草医药科技有限公司	一种匹伐他汀钙组合物
CN107913257A (zh) *	2016-10-10	2018-04-17	北京阜康仁生物制药科技有限公司	一种包含瑞舒伐他汀钙的药物组合物及其制备方法
JP6937195B2 (ja) *	2017-09-01	2021-09-22	興和株式会社	医薬組成物
WO2023275715A1 (en)	2021-06-30	2023-01-05	Pfizer Inc.	Metabolites of selective androgen receptor modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1327010C (en) *	1986-02-13	1994-02-15	Tadashi Makino	Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
CA1336714C (en) *	1987-08-20	1995-08-15	Yoshihiro Fujikawa	Quinoline type mevalonolactone inhibitors of cholesterol biosynthesis
US5030447A (en) *	1988-03-31	1991-07-09	E. R. Squibb & Sons, Inc.	Pharmaceutical compositions having good stability
JP3528186B2 (ja) *	1991-06-24	2004-05-17	日産化学工業株式会社	光学活性キノリンメバロン酸のジアステレオマー塩
HU217629B (hu) *	1991-12-12	2000-03-28	Novartis Ag.	Eljárás fluvasztatint tartalmazó stabilizált gyógyszerkészítmények előállítására

1996
- 1996-12-20 ES ES96942588T patent/ES2183023T3/es not_active Expired - Lifetime
- 1996-12-20 CN CNB961920653A patent/CN1137684C/zh not_active Expired - Lifetime
- 1996-12-20 CZ CZ19972681A patent/CZ288545B6/cs not_active IP Right Cessation
- 1996-12-20 KR KR1019970705768A patent/KR100348842B1/ko not_active IP Right Cessation
- 1996-12-20 CA CA002213608A patent/CA2213608C/en not_active Expired - Lifetime
- 1996-12-20 NZ NZ324446A patent/NZ324446A/xx not_active IP Right Cessation
- 1996-12-20 EP EP96942588A patent/EP0814782B1/en not_active Expired - Lifetime
- 1996-12-20 AU AU11715/97A patent/AU725622B2/en not_active Expired
- 1996-12-20 SK SK1160-97A patent/SK282991B6/sk not_active IP Right Cessation
- 1996-12-20 DE DE201112000014 patent/DE122011000014I1/de active Pending
- 1996-12-20 ZA ZA9610792A patent/ZA9610792B/xx unknown
- 1996-12-20 DE DE69625046T patent/DE69625046T2/de not_active Expired - Lifetime
- 1996-12-20 AT AT96942588T patent/ATE228354T1/de active
- 1996-12-20 WO PCT/JP1996/003722 patent/WO1997023200A1/en active IP Right Grant
- 1996-12-20 UA UA97084351A patent/UA29513C2/uk unknown
- 1996-12-20 SI SI9630566T patent/SI0814782T1/xx unknown
- 1996-12-20 RU RU97114095A patent/RU2142790C1/ru active
- 1996-12-20 PT PT96942588T patent/PT814782E/pt unknown
- 1996-12-20 PL PL96321868A patent/PL186907B1/pl unknown
- 1996-12-20 IL IL12156596A patent/IL121565A/en not_active IP Right Cessation
- 1996-12-20 DK DK96942588T patent/DK0814782T3/da active
- 1996-12-20 JP JP52350097A patent/JP3276962B2/ja not_active Expired - Lifetime
- 1996-12-20 HU HU9903536A patent/HU227798B1/hu unknown
- 1996-12-21 TW TW085115860A patent/TW436294B/zh not_active IP Right Cessation
1997
- 1997-08-19 NO NO19973814A patent/NO316724B1/no not_active IP Right Cessation
- 1997-08-21 MX MX9706389A patent/MX9706389A/es unknown
2011
- 2011-03-17 FR FR11C0007C patent/FR11C0007I2/fr active Active
- 2011-05-04 NO NO2011006C patent/NO2011006I2/no unknown

Also Published As

Publication number	Publication date
KR19980702370A (ko)	1998-07-15
UA29513C2 (uk)	2000-11-15
DK0814782T3 (da)	2002-12-16
FR11C0007I1 (pt)	2011-04-22
DE122011000014I1 (de)	2011-11-03
CZ268197A3 (cs)	1998-05-13
SI0814782T1 (en)	2003-04-30
IL121565A (en)	2002-02-10
HUP9903536A3 (en)	2001-06-28
TW436294B (en)	2001-05-28
CN1189098A (zh)	1998-07-29
HUP9903536A2 (hu)	2000-03-28
PL186907B1 (pl)	2004-03-31
NO2011006I2 (no)	2012-10-01
WO1997023200A1 (en)	1997-07-03
ZA9610792B (en)	1997-07-09
JPH11503763A (ja)	1999-03-30
NZ324446A (en)	1999-08-30
AU1171597A (en)	1997-07-17
HU227798B1 (en)	2012-03-28
NO973814D0 (no)	1997-08-19
CA2213608A1 (en)	1997-07-03
IL121565A0 (en)	1998-02-08
ATE228354T1 (de)	2002-12-15
FR11C0007I2 (fr)	2012-03-16
EP0814782B1 (en)	2002-11-27
RU2142790C1 (ru)	1999-12-20
EP0814782A1 (en)	1998-01-07
CZ288545B6 (cs)	2001-07-11
MX9706389A (es)	1998-08-30
NO973814L (no)	1997-10-13
PL321868A1 (en)	1997-12-22
CA2213608C (en)	2003-07-08
CN1137684C (zh)	2004-02-11
DE69625046D1 (de)	2003-01-09
AU725622B2 (en)	2000-10-19
SK116097A3 (en)	1998-03-04
JP3276962B2 (ja)	2002-04-22
DE69625046T2 (de)	2003-04-10
KR100348842B1 (ko)	2002-12-31
SK282991B6 (sk)	2003-01-09
NO2011006I1 (no)	2011-06-06
NO316724B1 (no)	2004-04-19
ES2183023T3 (es)	2003-03-16

Publication	Publication Date	Title
PT814782E (pt)	2003-04-30	Composicao farmaceutica estabilizada com um agente basico
RU92004564A (ru)	1995-05-10	Фармацевтические композиции и способ их получения
TR200302105T4 (tr)	2004-02-23	Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
ATE47715T1 (de)	1989-11-15	Stabile salze von sam mit polyanionen.
CA2391076A1 (en)	2001-05-25	Solutions containing epinastin
BR0010194A (pt)	2002-02-13	Composição farmacêutica sob a forma unitária, contendo o ácido acetilsalicìlico e hidrogenossulfato de clopidogrel
PL357132A1 (en)	2004-07-12	Stable, nasally, orally or sublingually applicable pharmaceutical preparation
RS50445B (sr)	2010-03-02	Farmaceutski rastvori levosimendana
IT1247945B (it)	1995-01-05	Agente avente attivita' batteriostatica e battericida
ES2138940T1 (es)	2000-02-01	Quelactantes de plata del acido etilendiamintriacetico y del acido n-acil etilendiamintriacetico.
EP0208519A3 (en)	1987-08-12	Solubilized composition of hardly-soluble pharmaceutical product
CA2057291A1 (en)	1992-06-12	A stable pharmaceutical composition of human calcitonin
CA2016968A1 (en)	1991-02-23	Air freshener composition
IS6654A (is)	2002-12-11	Stöðugt gabapentín með pH innan stýrðra marka
KR880013557A (ko)	1988-12-21	신규 안과용 조성물
NZ337798A (en)	2001-03-30	Pharmaceutical compositions containing lamivudine
EP0397147A3 (en)	1991-06-12	Stable solutions of rebeccamycin analog and preparation thereof
KR910014122A (ko)	1991-08-31	에토포시드-2-디메틸아미노 화합물의 동결건조 제제
CO5070673A1 (es)	2001-08-28	Composiciones farmaceuticas en forma de solucion estable que comprenden (1s,4r)-cis-4-(2-amino-6-(ciclopropilamino)-9h -purin-9-il)-2-ciclopenteno-1-metanol, un quelador de metal y un agente endulzante
ES2149736T1 (es)	2000-11-16	Composiciones farmaceuticas conteniendo derivados de tienopiridina estables y libres de antioxidantes.
DE69602208D1 (de)	1999-05-27	Stabilisierte pharmazeutische zusammensetzungen enthaltend dobutamine
AU6243094A (en)	1994-09-14	Stable aqueous acid compositions thickened with polyacrylamide
RU94019970A (ru)	1995-11-10	Водный раствор спарфлоксацина, способ его получения и соль спарфлоксацина и фармацевтическая композиция
KR960021045A (ko)	1996-07-18	페루릭산을 포함하는 b형 간염 치료제
KR960021046A (ko)	1996-07-18	카페익산을 포함하는 b형 간염 치료제